Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Stallmach

Showing results (51-60 of 318) with videos related to

Pageof 32
Sort By:
International Journal of Colorectal Disease|November 5, 2022
Correction to: Disease recurrence in patients with Crohn's disease after biologic therapy or surgery: a meta-analysisSarah Kneißl, Johannes Stallhofer, Peter Schlattmann, et al.
Viszeralmedizin|November 12, 2015
Medical Therapy of Active Ulcerative ColitisMartin Bürger, Carsten Schmidt, Niels Teich, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2023
Review article: Translating STRIDE-II into clinical reality - Opportunities and challengesAxel Dignass, Stefan Rath, Thomas Kleindienst, et al.
Deutsche Medizinische Wochenschrift (1946)|August 30, 2017
[Multiple Hemorrhagic Skin Lesions in a 52-Year-Old Patient with Liver Cirrhosis]Carolin Fleischmann, Andreas Herrmann, Jörg Felber, et al.
BMC Gastroenterology|March 1, 2013
Attenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytesJack Peter, Oliver Frey, Andreas Stallmach, et al.
Visceral Medicine|April 8, 2024
Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent <i>Clostridioides difficile</i> InfectionJohannes Stallhofer, Arndt Steube, Katrin Katzer, et al.
Journal of Hepatology|February 21, 2025
Both the timing of the measurement and the adjustment of the portal pressure gradient (PPG) after TIPS implantation are importantAlexander Zipprich, Philipp Reuken, Andreas Stallmach, et al.
Alimentary Pharmacology & Therapeutics|August 26, 2023
Editorial: If STRIDE-II is the hammer, then Crohn's disease and ulcerative colitis are not the same nails-Authors' replyAxel Dignass, Stefan Rath, Thomas Kleindienst, et al.
International Journal of Colorectal Disease|September 23, 2022
Disease recurrence in patients with Crohn's disease after biologic therapy or surgery: a meta-analysisSarah Kneißl, Johannes Stallhofer, Peter Schlattmann, et al.
Alimentary Pharmacology & Therapeutics|November 21, 2023
Letter: The importance of histological assessment-a further stride in STRIDE. Authors' replyAxel Dignass, Stefan Rath, Thomas Kleindienst, et al.
Pageof 32

Showing results (51-60 of 318) with videos related to

Sort By:
Pageof 32
International Journal of Colorectal Disease|November 5, 2022
Correction to: Disease recurrence in patients with Crohn's disease after biologic therapy or surgery: a meta-analysisSarah Kneißl, Johannes Stallhofer, Peter Schlattmann, et al.
Viszeralmedizin|November 12, 2015
Medical Therapy of Active Ulcerative ColitisMartin Bürger, Carsten Schmidt, Niels Teich, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2023
Review article: Translating STRIDE-II into clinical reality - Opportunities and challengesAxel Dignass, Stefan Rath, Thomas Kleindienst, et al.
Deutsche Medizinische Wochenschrift (1946)|August 30, 2017
[Multiple Hemorrhagic Skin Lesions in a 52-Year-Old Patient with Liver Cirrhosis]Carolin Fleischmann, Andreas Herrmann, Jörg Felber, et al.
BMC Gastroenterology|March 1, 2013
Attenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytesJack Peter, Oliver Frey, Andreas Stallmach, et al.
Visceral Medicine|April 8, 2024
Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent <i>Clostridioides difficile</i> InfectionJohannes Stallhofer, Arndt Steube, Katrin Katzer, et al.
Journal of Hepatology|February 21, 2025
Both the timing of the measurement and the adjustment of the portal pressure gradient (PPG) after TIPS implantation are importantAlexander Zipprich, Philipp Reuken, Andreas Stallmach, et al.
Alimentary Pharmacology & Therapeutics|August 26, 2023
Editorial: If STRIDE-II is the hammer, then Crohn's disease and ulcerative colitis are not the same nails-Authors' replyAxel Dignass, Stefan Rath, Thomas Kleindienst, et al.
International Journal of Colorectal Disease|September 23, 2022
Disease recurrence in patients with Crohn's disease after biologic therapy or surgery: a meta-analysisSarah Kneißl, Johannes Stallhofer, Peter Schlattmann, et al.
Alimentary Pharmacology & Therapeutics|November 21, 2023
Letter: The importance of histological assessment-a further stride in STRIDE. Authors' replyAxel Dignass, Stefan Rath, Thomas Kleindienst, et al.
Pageof 32